Active Implantable Medical Devices Market Global Insights 2021 - Abbott Laboratories, Boston Scientific Corporation, Cochlear Limited, Medtronic PLC

Global Active Implantable Medical Devices market gives essential information, objective insights regarding global market top key players analysis, and much more. The report provides detailed information on segmentation which covers product type, various components, end-user or applications, and various regions. The report deals with the most driving forces influencing the market’s revenue scale. The report delivers a comprehensive analysis of key segments, recent trends, major drivers, growth constraints, competitive landscape during this market. The impact of the COVID-19, and also forecasts its recovery post-COVID-19. The report also presents forecasts for Active Implantable Medical Devices investments from 2021 till 2025.

The global Active Implantable Medical Devices market is expected to witness a CAGR of 7.2% during the forecast period.

Click Here to Get Free Sample PDF Copy of Latest Research on Active Implantable Medical Devices Market 2021 Before Purchase:

https://www.marketinsightsreports.com/reports/10192357644/active-implantable-medical-devices-market-growth-trends-and-forecasts-2020-2025/inquiry?Mode=18

Market Overview: -

The increasing geriatric population is one of the important drivers propelling the growth of the market. The number of people aged 65 or older is projected to increase from 524 million in 2010, to nearly 1.5 billion in 2050, representing about 16% of the worlds population. Furthermore, increasing chronic diseases coupled with the advancements in the active implantable medical devices are projected to boost the market growth. However, rising demand for non-invasive procedures, issues related to implantable devices and high cost of the devices anticipated to impede the market growth.

Competitive Landscape: -

In November 2017, Medtronic PLC has announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure pacemakers with BlueSync technology. Available in both single chamber and dual chamber models, the Azure XT MRI and Azure S MRI pacemakers offer improved longevity, estimated at 13.7 years (dual chamber) or 27 percent longer than its previous version.

Companies like Abbott Laboratories, Biotronik Se & Co., Kg, Boston Scientific Corporation, Cochlear Limited, Livanova PLC, Med-EL, Medtronic PLC, Nurotron Biotechnology Co. Ltd., William Demant Holding A/S, among others, hold the substantial market share in the Active Implantable Medical Devices market.

Key Market Trends: -

Implantable Cardiac Pacemaker is Expected to Witness Healthy Growth Over the Forecast Period

The implantable pacemakers are of three major types, namely, single-chamber, dual-chamber, and biventricular pacemakers. The growth of the segment can be attributed to factors, such as reduced post-surgical complications and the presence of multiple leads in order to assure normal physiology of the heart.

According to the American College of Cardiology, cardiovascular disease (CVD) accounted for 800,000 deaths in the United States in 2017 alone. Among Americans, an average of one person dies from cardiovascular disease, every 40 seconds. Coronary heart disease (CHD) accounts for the majority of CVD deaths, followed by stroke and heart failure. According to the European Heart Network, every year, cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). The implantable pacemaker segment is growing rapidly, due to increasing R&D funding for healthcare and increasing R&D trends in emerging economies.

North America Dominates the Market and Expected to do Same in the Forecast Period

The rising prevalence of cardiovascular diseases, high obesity rates, and favorable reimbursement environments are the primary factors which are driving the market growth. According to American Heart Association (AHA) estimates about 5.7 million adults in the United States are suffering from congestive heart failure. And about one in nine deaths include heart failure as contributing cause. As per Centers for Disease Control and Prevention (CDC) statistics, more than three million people in the United States suffer from atrial fibrillation, which is the most common type of abnormal heart rhythm. Furthermore, the number is expected to quadruple by 2050, as the population ages.

Significant Features that are under Offering and Key Highlights of the Reports:

– Detailed overview of Active Implantable Medical Devices Market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application, etc.
– Historical, Current, and projected market size in terms of volume and value
– Recent industry trends and developments
– Competitive landscape of Active Implantable Medical Devices Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth

Click the link to Browse This Full Report @:

https://www.marketinsightsreports.com/reports/10192357644/active-implantable-medical-devices-market-growth-trends-and-forecasts-2020-2025?Mode=18

Contact Us:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: +1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and Chinese and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.